Satsuma Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 10.29 million compared to USD 15.52 million a year ago. Basic loss per share from continuing operations was USD 0.31 compared to USD 0.49 a year ago.
Satsuma Pharmaceuticals, Inc.
Equities
STSA
US80405P1075
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
-2.95% | 102B | |
+2.11% | 96.29B | |
+2.13% | 22.18B | |
-15.22% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.29% | 16.36B | |
+5.49% | 13.97B | |
+33.28% | 12.17B |